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In Brief Lin, Tsai et al. introduce a chemicalgenetic toolkit for photo-controlling individual types of GABA A receptors, which mediate inhibitory synaptic transmission in the brain. Photo-control of inhibition operates with spatial, temporal, and biochemical precision, allowing subcellular-to-systems-level analysis.
INTRODUCTION GABA (g-aminobutyric acid) is the main inhibitory neurotransmitter in the brain, acting in counterpoint to glutamate, the main excitatory neurotransmitter. The delicate balance between GABAergic inhibition and glutamatergic excitation is essential for normal sensory processing, motor pattern generation, and cognitive function. Abnormalities in GABA-mediated inhibition have devastating consequences, contributing to pathological pain (Zeilhofer et al., 2012) , movement disorders (Galvan and Wichmann, 2007) , epilepsy (Treiman, 2001 ), schizophrenia (Guidotti et al., 2005) , and neurodevelopmental disorders (Ramamoorthi and Lin, 2011) .
GABA exerts its effects largely through ligand-gated Cl À channels known as GABA A receptors (Farrant and Nusser, 2005) . GABA A receptors are heteropentamers containing two a, two b, and one tertiary subunit. The a subunit contributes to GABA binding and determines gating kinetics and subcellular localization of the receptor (Olsen and Sieghart, 2009; Picton and Fisher, 2007; Rudolph and Mö hler, 2014) . There are six a subunit isoforms expressed differentially during development and across brain regions , but the distinct functions of individual isoforms remain elusive. Pharmacological agents, including agonists, competitive antagonists, and allosteric modulators, have been the main instruments for elucidating the function of GABA A receptors. However, these tools are limited by the low spatial and temporal precision of drug application. Moreover, accurate manipulation of GABA A isoforms has been hindered by the lack of subtype-specific agonists or antagonists for the GABA-binding site. There are subtype-selective allosteric modulators for the benzodiazepine-binding site, but they have limited specificity and/or low efficacy (Rudolph and Mö hler, 2014) . Gene knockout technology provides an alternative strategy for deducing the function of GABA A isoforms, but removal of one a subunit can lead to compensatory changes in the expression of other receptors and ion channels (Kralic et al., 2002; Ponomarev et al., 2006; Brickley et al., 2001) .
For these reasons, we have developed an optogenetic pharmacology strategy that enables isoform-specific photo-control of the entire GABA A receptor family and, by extension, all GABA A -mediated inhibition in the brain. We show that photocontrol can be implemented at all levels, from investigating subcellular receptor distribution to regulating visual cortical activity in vivo. Finally, we introduce a transgenic mouse that allows, for the first time, photo-control of an endogenous neurotransmitter receptor. Instead of controlling an exogenous optogenetic tool that overpowers the native electrophysiology of neurons (e.g., NpHR or Arch; Zhang et al., 2011) , our approach allows direct manipulation of the brain's own GABA A receptors, a powerful strategy for understanding the roles they play in health and disease.
RESULTS
The Light-Regulated GABA A Receptor Toolkit The GABA A receptor has two GABA-binding sites, each at the interface of a and b subunits ( Figure 1A ). Light-regulated GABA A receptor (LiGABAR) is generated by conjugating a photoswitchable tethered ligand (PTL) onto a cysteine genetically engineered into the a subunit near the GABA-binding site. The PTL molecule has three chemical modules ( Figure 1B ): a cysteine-reactive maleimide group (for receptor conjugation), an azobenzene core (for photoswitching), and a GABA-site ligand (for competitive antagonism). The azobenzene adopts an extended trans configuration in darkness and a twisted cis configuration in 360-to 400-nm light. The cis isomer slowly reverts to the trans form in darkness, but this process can be accelerated with 460-to 560-nm light. Hence, photo-control is bidirectional. Depending on where the PTL is attached, either the cis or the trans isomer antagonizes the receptor, and photoswitching to the alternative configuration alleviates antagonism ( Figure 1A ).
We previously developed PTLs with muscimol as the parent ligand (linked to azobenzene via N-acylation; Lin et al., 2014) . Although these compounds do impart light sensitivity on GABA A receptors, their low efficacy limited the magnitude of photoswitching in vitro and their poor solubility (<50 mM) excluded their use in vivo. To improve efficacy, we made new PTLs with either GABA or its guanidinium analogs as the ligand ( Figure 1B ; Figure S1 ). We expected that these PTLs would be antagonists, like other ester or amide derivatives of GABA (Matsuzaki et al., 2010) . The diffuse positive charge of the guanidinium group may enhance ionic, hydrogen-bond, and/or cationp interactions with the receptor (Bergmann et al., 2013; Miller and Aricescu, 2014) , and protonation of amino/guanidine groups at neutral pH should enhance water solubility of the PTLs. Figure S2 ). Photosensitivity is described as the percent decrease of peak current by photo-antagonism. Data are plotted as mean ± SEM (n = 4-6).
(F) The PTL attachment site for each a isoform. The sequences of loop E in rat a1-a6 subunits are aligned. Sites for cysteine substitution are shown in bold orange.
Recordings for (C)-(E) were carried out in HEK cells held at À70 mV. See also Figures S1-S3.
The new PTLs were conjugated onto a series of cysteine mutants of a1 ( Figure S1 ), coexpressed with wild-type b2 and g2 in HEK293 cells. The optimal combination of PTL and cysteine mutant was PAG-1C ( Figure 1B ) and a1T125C (Figures 1C-1F ; Figure S1 ). As expected, the GABA-elicited current was strongly reduced in 500-nm light (trans-PTL) and completely restored in 380-nm light (cis-PTL; Figure 1C ). Cis-to-trans photoisomerization reduced the response to half-saturating GABA by 78% ± 2% (10 mM, n = 6; Figure 1E ) and to saturating GABA by 57% ± 2% (300 mM, n = 6). Dose-response curves showed that the EC 50 (half-maximal effective concentration) increased from 15.3 ± 6.0 mM (n = 6) to 583 ± 139 mM (n = 4) when the PTL was switched from cis to trans ( Figure 1D ), consistent with the induction of competitive antagonism. Receptor activation was indistinguishable from wild-type with the PTL in the cis configuration (wild-type EC 50 = 9.5 ± 2.3 mM, n = 7, p > 0.1, two-tailed t test). Taken together, the discovery of PAG-1C for a1-LiGABAR validates the PTL design and establishes effective photo-control of this receptor isoform.
We next applied the PTL strategy to all other a isoforms (a2-a6) to obtain the complete LiGABAR toolkit. We paired cysteine mutants of a subunits (focusing on loop E, where a1T125C is located) with a library of PTLs, and the resulting LiGABARs were evaluated in HEK293 cells. These PTLs varied in their ligands (GABA, guanidinylated GABA, and guanidine acetic acid; Figure S1 ) and spacer lengths between the ligand and the azobenzene. For each isoform, we selected the best PTL/ mutant pair (Figures 1E and 1F ; Figure S2 ) based on two criteria: (1) GABA-elicited currents are robustly photo-controlled (preferably R50% photo-antagonism at EC 50 ), and (2) receptor function is unaffected by cysteine mutation and PTL conjugation.
Notably, we found a homologous mutation site that enables the reversed polarity of photo-control (i.e., antagonizing the receptor by cis-PTL). When a longer PTL (e.g., PAG-2A, PAG-2B, or PAG-3C in Figure 1B ) is conjugated onto this site, GABA-elicited current is reduced in 380-nm light by 45%-70% and is fully restored in 500-nm light (Figures 1E and 1F, ; 48% ± 5% reduction by PAG-3C on a1T121C, n = 3). Interestingly, some of the mutants enable either a cis or trans mode of photo-antagonism when conjugated with a longer or a shorter PTL, respectively (e.g., a2 and a5 LiGABARs in Figure 1E ). This dual option adds flexibility in whether or not the receptor will be turned off in the ground state (i.e., in darkness), an important consideration for applications in neural circuits.
Even though all of the receptors have a cysteine point mutation, this change appears to have minimal effects on receptor function, unless the PTL is conjugated and switched to the antagonizing configuration. None of the cysteine mutations, by themselves, alter receptor activation ( Figure S2 ). Moreover, neither cysteine substitution nor PTL conjugation affects the characteristic properties of the parent receptor, such as allosteric modulation at the benzodiazepine site or anion permeability of the channel ( Figure S2 ). Hence, LiGABARs function as their normal receptor counterparts until the moment they are photo-antagonized by a conjugated PTL.
Wild-type GABA A receptors, which lack a properly positioned cysteine near the GABA-binding pocket, remain insensitive to light after PTL treatment ( Figures S1 and S3 To validate this idea, we mapped the functional distributions of a1-and a5-LiGABARs in hippocampal CA1 pyramidal neurons. The cysteine mutant of the a1 or a5 subunit (a1T125C or a5E125C) was virally coexpressed with GFP in a rat hippocampal slice. The transduced slice was then treated with PTL (PAG-1C), and fluorescent neurons were selected for wholecell voltage-clamp recording. We monitored responses to uncaged GABA when LiGABARs were either antagonized (by 540 nm) or relieved from antagonism (by 390 nm). By measuring the ratio of responses in these two conditions, we reveal the contribution of a particular a isoform to the uncaging response and control for potential sources of variability. Other control experiments demonstrate that the two-photon uncaging response was unaltered by the conditioning light for receptor photo-control ( Figure S4A ; validated in the absence of the PTL), and that the two-photon light used for uncaging did not affect the state of the LiGABAR ( Figure S4B ).
We first obtained a low-resolution view of where a1-and a5-LiGABARs are present (Figures 2A and 2B ). Two locations were examined: one at or close to the soma (proximal site), and one on the primary apical dendrite (70-80 mm from the soma; distal site). Each uncaging site spanned 7-10 mm. In cells expressing a1-LiGABAR, photoswitching (defined as the fraction of current antagonized by light) was more profound proximally than distally, with the effect decreasing from 0.47 ± 0.02 at the proximal site to 0.11 ± 0.07 at the distal site (p < 0.05, n = 5, paired t test; Figures 2A and 2C) . In contrast, when a5-LiGABAR was expressed, photoswitching was not significantly different between the two sites (0.33 ± 0.09 at the proximal site and 0.50 ± 0.06 at the distal site; p > 0.1, n = 5, paired t test; Figures  2B and 2C ). These results suggest that functionally active a1-and a5-GABA A receptors are differentially distributed, with a1 concentrated near the soma and a5 extending to more distal locations along the apical dendrite.
We next obtained a higher-resolution map of dendritic a1-and a5-LiGABARs with smaller, more closely spaced uncaging spots (2.5 mm, $5 mm apart; Figures 2D and 2E ). We found that the amplitude of GABA-elicited current varied between these spots in neurons expressing either a1 or a5. Independent of this, however, there was a striking difference in the spatial pattern of photoswitching between these two isoforms ( Figures 2D-2G ). Photosensitivity appeared to be localized to ''hotspots'' for a1 ( Figures 2D and 2F ) but distributed evenly along the dendrite for a5 (Figures 2E and 2F) . Group data show higher spatial variability of photoswitching for neurons expressing a1-LiGABAR than for those expressing a5-LiGABAR, consistent with clustering of a1-containing receptors (coefficient of variation: 0.59 for a1 versus 0.18 for a5, p < 0.05, Levene's test, n = 22 and 18 uncaging sites from five and six cells, respectively; Figure 2G ).
Immunolabeling studies showed that the a1 isoform is concentrated at inhibitory synapses (Brü nig et al., 2002; Kasugai et al., 2010) . To verify that the photoswitching hotspots of a1-LiGABAR represent clusters of functional receptors at synapses, we targeted inhibitory synapses using a genetically encoded fluorescent intrabody for gephyrin (a scaffolding protein that tethers GABA A receptors at synapses; Gross et al., 2013) . Neurons expressing the gephyrin intrabody exhibit fluorescent puncta at postsynaptic sites. We found significant photoswitching of responses only when GABA was uncaged at gephyrin puncta (0.32 ± 0.07 at puncta versus À0.01 ± 0.03 at $4 mm outside of puncta, n = 7 and 5 sites from five cells, respectively, p < 0.001, paired t test; Figures 2H and 2I). Hence, by combining LiGABAR photo-control with two-photon uncaging, one can generate a functional map of a specific GABA A isoform on a neuron, resolved at the level of individual synaptic contacts.
Photo-Control of Synaptic Inhibition with LiGABARs
We next tested whether LiGABARs can enable photo-control of inhibitory postsynaptic currents (IPSCs). Mutant a subunits were exogenously expressed by viral transduction in mouse cerebral cortex. Brain slices were treated with PTLs to generate LiGABARs. Monosynaptic IPSCs were evoked by electrical stimulation of local inhibitory inputs while blocking excitatory glutamate receptors.
When we employed a LiGABAR that exhibits trans-antagonism (PAG-1C on a1), we found that IPSC amplitude was 63% ± 3% smaller in 500-nm light than in 380-nm light (p < 0.05, n = 6, paired t test; Figure 3A ). When we used a LiGABAR that exhibits cis-antagonism (PAG-2A on a5), we observed the opposite effect: IPSC amplitude was 52% ± 2% smaller in 380-nm light than in 500-nm light (p < 0.05, n = 6, paired t test; Figure 3B ). Hence, synaptic inhibition can be photo-controlled with either polarity.
In principle, the amplitude of IPSCs can be changed by altering presynaptic GABA release or postsynaptic GABA A receptors. To verify that our observed effects are entirely postsynaptic, we compared the paired-pulse ratio (PPR) at the two photoswitching wavelengths. Changes in PPR would reflect changes in presynaptic release probability (Zucker and Regehr, 2002) . We found that the PPR was the same under 380-and 500-nm illumination (0.9 ± 0.1 versus 0.9 ± 0.1, p > 0.05, n = 11, paired t test), indicating that photoswitching was entirely a postsynaptic phenomenon.
Extrasynaptic GABA A receptors mediate tonic inhibition, important for setting the tone of excitability in the brain (Farrant and Nusser, 2005) . To test whether LiGABARs enable photocontrol of tonic inhibition, we recorded from hippocampal pyramidal neurons expressing a5-LiGABAR (conjugated with PAG-1C). To magnify GABA-mediated currents, neurons were clamped at 0 mV, far from the E Cl (chloride reversal potential; À70 mV), and a small volume of artificial cerebrospinal fluid (aCSF; $30 ml) was recirculated to avoid washout of extracellular GABA. Under these conditions, a brief flash of 390-nm light caused an outward current increase of 52 ± 13 pA (n = 5) that was reversed by 540-nm light ( Figure 3C ). The effect of light was abolished after applying picrotoxin (100 mM), confirming that it was mediated by GABA A receptors.
Our results suggest that viral expression of the LiGABAR mutant alone, in the absence of the photoswitch, did not significantly alter synaptic properties. We compared the ratio of excitatory and inhibitory synaptic currents (E/I ratio) in a1T125C-expressing versus nonexpressing neurons in cortical slices. The E/I ratio was the same in mutant-expressing neurons and in control neurons, and there was no difference in the kinetics of IPSCs between the two groups ( Figure S5 ). Taken together, LiGABARs can be exogenously introduced into brain tissue without changing the balance between synaptic excitation and inhibition.
Kinetics of LiGABAR Photo-Control
Optogenetic tools allow rapid manipulations of neuronal activities with temporal precision. To test the speed of LiGABAR photo-control, we measured the minimal illumination time required for full IPSC photoswitching in CA1 pyramidal neurons with a1-LiGABAR. A flash of 540-nm (28 mW/mm 2 ) or 390-nm (4.5 mW/mm 2 ) light was applied 100 ms prior to presynaptic stimulation to antagonize or restore the receptor, respectively. We first fully antagonized LiGABAR with a fixed duration of 540-nm light (500 ms) and restored receptor activity with various durations of 390-nm light (ranging from 10 to 500 ms; Figure 4A ). Photoswitching (relief of antagonism) increased with increasing duration of 390-nm light, and approached maximal (>95%) with a 100-ms flash. We next repeated the experiment with different durations of 540-nm light (and fixed 390-nm flashes; Figure 4A ). In this case, photoswitching (induction of antagonism) approached maximal with a 200-ms flash of 540-nm light. We next tested whether rapid control of synaptic inhibition could change the spike output of a neuron in response to synaptic stimulation. Current-clamp recordings were carried out in CA1 pyramidal neurons expressing a1-LiGABAR. We electrically stimulated Shaffer collaterals, recruiting overlapping excitatory and inhibitory synaptic inputs that have opposite effects on spiking. Each stimulus elicited a single spike when LiGABAR was photo-antagonized. The spike was eliminated when LiGABAR was relieved from antagonism. The spiking response could be gated with a flash of light as brief as 100 ms, delivered immediately before the presynaptic stimulus Left: representative traces. Right: changes in peak IPSC amplitudes in darkness (white), 380-nm light (violet), and 500-nm light (green). Data are plotted as mean ± SEM. Note the opposite polarity of photo-control and the different default level of IPSCs (in darkness) in (A) and (B). See also Figure S5 . (C) Photo-control of tonic currents by a trans-antagonist (PAG-1C, conjugated to a5E125C). Light intensity was 4.5 mW/mm 2 for 390 nm and 28 mW/mm 2 for 540 nm. Current levels were sustained after light flashes due to the bistability of LiGABAR (see Figure 4C ). Photo-control was abolished after all of the GABA A receptors (including a5-LiGABAR) were blocked by picrotoxin (100 mM).
Recordings were carried out in cortical (A and B) or hippocampal (C) pyramidal neurons held at 0 mV.
( Figure 4B ). Collectively, our results ( Figures 4A and 4B ) suggest that inhibition can be photo-controlled at a timescale of 100-200 ms. Because the speed of photo-control is largely determined by light intensity, LiGABAR manipulation may be accelerated further with a brighter light source. LiGABARs can also be used as a bistable switch. To illustrate this feature, we monitored the IPSC amplitude after transient conditioning with 380-or 500-nm light ( Figure 4C ). The IPSC amplitude was elevated by 380-nm light, and slowly decreased upon returning to darkness with a time constant of 30 ± 6 min (95% confidence bounds: 26 ± 4 min and 38 ± 8 min; n = 4). Exposure to 500-nm light quickly reduced the IPSC back to the initial amplitude, where it remained steady over 10 min. Hence, LiGABAR can be stably toggled between antagonized and antagonism-relieved states with brief flashes of conditioning light. This feature minimizes phototoxicity and enables the use of other optical manipulations in the same experiment (e.g., GABA uncaging; Figure 2 ).
Spatial Reach of LiGABAR Photo-Control in the Brain
Before implementing LiGABAR in vivo, we needed to define how far the PTL and the light can penetrate through brain tissue to enable photo-control. We first determined how deep into the cerebral cortex the PTL can penetrate to form LiGABAR ( Figures 5A-5C ). To evaluate this parameter, we first expressed the mutant a subunit by stereotactically injecting a virus (encoding a1T125C and eGFP) into mouse visual cortex. After 10-14 days, the mouse was anesthetized, and a craniotomy was performed to expose the cortex where neurons expressed the mutant receptor. Following the subsequent duratomy, a droplet of aCSF containing the PTL (250 mM PAG-1C) was applied onto the exposed brain surface ( Figure 5A ).
After 1 hr of treatment, we prepared cortical slices and recorded from GFP-positive neurons at various depths beneath the craniotomy region. The degree of IPSC photoswitching was assessed as an index of LiGABAR formation. We found that the degree of IPSC photoswitching declined with the depth from the pia, decreasing from $40% near the surface to $0% at 400 mm away from the surface ( Figure 5B ). This decline in IPSC photosensitivity could be fit with a single exponential function with a depth constant of 371 mm (95% confidence bounds: 239 and 824 mm; n = 15 cells from three mice; Figure 5C ).
We next used a brain slice as a surrogate for intact brain tissue to evaluate how far the light can penetrate to photo-control LiGABAR (Figures 5D-5F ). We prepared acute cortical slices from virally transduced mice, and incubated the slices in PTLcontaining aCSF to allow uniform receptor conjugation. In each neuron, we measured the ratio of IPSC photoswitching under two different illumination conditions: first, with light projected directly into the slice axially from the pia surface and, second, with light projected directly onto the slice in cross-section (Figure 5D ). Axial illumination should photo-control LiGABAR maximally near the pia surface, where light intensity is highest. Cross-sectional illumination should photo-control LiGABAR uniformly, with variability attributable to other factors, such as differences in the expression of the mutant subunit. Hence, the ratio of IPSC photoswitching by axial versus cross-sectional illumination reflects the efficiency of LiGABAR photo-control, calibrating for other factors that could cause cell-to-cell variation. We found that IPSC photoswitching by axial illumination decreased from $41% near the pia surface to $11% at $400 mm from the surface ( Figure 5E ). The depth-dependent decrease of photoswitching ratio (axial versus cross-sectional) could be fit with a single exponential function with a depth constant of 352 mm (95% confidence bounds: 255 and 568 mm; n = 12 cells from three mice; Figure 5F ). These experiments utilized an unfocused light source for axial illumination, which emitted at $15 mW/cm 2 for both wavelengths of light. A brighter or more focused light source, or an implanted optrode system, should allow an even deeper photo-control. Taken together, these experiments suggest that both the PTL and the light can effectively reach as deep as $350 mm from the brain surface, extending through layer 2/3 of mouse cerebral cortex.
Photo-Control of Cortical Visual Responses In Vivo
Once we established that both the PTL and the light can penetrate into brain tissue to control inhibition at a sufficient depth, we tested whether photo-control is effective in vivo. Specifically, we asked whether photo-control of LiGABAR could alter information processing in the primary visual cortex (V1) of a mouse as it is responding to a visual stimulus (Figure 6 ). The LiGABAR mutant was virally introduced into mice 2 weeks before the experiments. After the mouse underwent anesthesia, craniotomy, and PTL treatment, we made extracellular loose-patch recordings from LiGABAR-expressing, parvalbumin-positive (PV+) interneurons in layer 2/3 ( Figures 6A and 6B ). We first confirmed that the visual stimulus, a 100% contrast drifting square grating, evoked spikes in the recorded neurons. To toggle LiGABAR between the antagonized and nonantagonized states, we delivered a full-field spot of conditioning light (390 or 470 nm) into the cortex through a microscope objective. Because LiGABAR is bistable ( Figure 4C ), a brief illumination of conditioning light (10 s) was sufficient to switch the receptor state for several minutes. This provided a time window for any spurious response to the conditioning light to decay before the onset of the visual stimulus.
We found that the pattern of spiking in PV+ neurons, during the visual response, changed from burst firing after conditioning with 470-nm light (antagonism induced) to sustained firing after conditioning with 390-nm light (antagonism relieved) ( Figure 6C) . Moreover, the average increase in spike rate during the visual stimulus was larger when LiGABAR was antagonized. Changes in spike rate evoked by the visual stimulus could be modulated up and down repeatedly by switching the conditioning light back and forth (n = 7 cells from four mice, p < 0.05, one-way ANOVA; Figure 6D ). Control experiments showed that neither the mutant alone nor the PTL alone enabled photo-control of visual responses (mutant alone, n = 6 cells from two mice, p > 0.05, one-way ANOVA; PTL alone, n = 9 cells from two mice, p > 0.05, one-way ANOVA; Figure 6D ). Taken together, these results show that LiGABAR can be introduced into a mouse brain for in vivo photo-control. Furthermore, our findings support the notion that GABAergic inhibition in PV+ neurons plays a role in information processing in the visual cortex, such as setting the gain and determining the temporal dynamics of the visual response (Katzner et al., 2011). 
A Knockin Mouse for Optical Control of Endogenous a1-GABA A Receptors
Our results suggest that in cortical pyramidal neurons, overexpression of a mutant a subunit causes no significant changes in IPSC kinetics or E/I ratio ( Figure S5 ). However, unadulterated expression in all neurons can only be assured by replacing the gene encoding the wild-type a subunit with its mutant counterpart.
To bring about exact genomic substitution, we generated a knockin mouse in which a single point mutation (T125C) was introduced into the gene of the a1 subunit through homologous recombination ( Figure S6 ). We named this knockin the a1-GA-BA A photoswitch-ready mutant (PhoRM) mouse. Immunohistochemical analysis confirmed that the expression pattern of the mutant a1 was identical to that of the wild-type. Immunolabeling profiles through tissue slices from cerebral cortex, hippocampus, and cerebellum ( Figures 7A-7F) were the same for the a1-GABA A PhoRM mouse as for the wild-type.
Functionally, we examined the expression of a1T125C by measuring IPSC photoswitching in PAG-1C-treated brain slices. We compared photoswitching in neuronal cell types that differ in the relative abundance of a1 with respect to other a isoforms ( Figures 7G and 7H ). We used cell types thought to express only the a1 isoform (cerebellar molecular layer interneurons and Mohler, 1995) . Photoswitching was the strongest in MLIs and PCs (51% ± 2% and 50% ± 2%, n = 7 and 6 cells from two and three mice, respectively), intermediate in L5 PYNs (30% ± 2%, n = 6 cells from two mice), and nonexistent in GoCs (À2% ± 3%, n = 5 cells from three mice). Hence, the degree of photoswitching is correlated with the relative abundance of a1 in a neuron.
Photo-Control of Sensory Responses and g Oscillations in the a1-GABA A PhoRM Mouse
Understanding the role of inhibition in the cortex has often relied on nonspecific blockers or antagonists of GABA A receptors. The a1-GABA A PhoRM mouse provides the unprecedented opportunity to selectively and reversibly remove a particular endogenous receptor from a functional neural circuit both in vitro and in vivo. We used a multielectrode probe to record extracellular spiking activity in neurons in the visual cortex of the awake a1-GABA A PhoRM mouse. We applied the PTL by intracranial infusion through a micropipette inserted $275 mm into the cortex (Figure 8A) , an alternative approach to topical application on the brain surface.
We examined the response of neurons to a visual stimulus train that consisted of 10 full-contrast checkerboard images. We applied brief conditioning flashes to switch a1-LiGABAR 5 s before each episode of the stimulus train. In many neurons (15/43 cells in three PTL-treated mice, p < 0.05, Friedman test over episodes), conditioning flashes that either induced or relieved antagonism reliably changed visually evoked spiking activity. Owing to its inhomogeneous distribution pattern in the brain (Figure 7 ; Fritschy and Mohler, 1995) , we surmised that photo-controlling a1-LiGABAR might result in heterogeneous effects on cortical neurons. Indeed, some neurons showed a significant increase in firing rate after photo-antagonism (top of Figures 8B and 8C) , whereas other neurons showed a significant decrease (bottom of Figures 8B and 8C) . Photoswitching occurred in a larger fraction of fast-spiking neurons (FS cells; 12/28) than regular spiking neurons (RSs; 3/15) ( Figure 8D ; see classification of FS and RS cells in Figure S7 ). In control mice infused with vehicle alone, only 1/28 FS cells and 1/16 RS cells exhibited photosensitivity (2/44 cells in two mice, p < 0.05, Friedman test over episodes), confirming that spike modulation was specifically a consequence of LiGABAR photo-control.
FS cells have been identified as mostly PV+ interneurons (Avermann et al., 2012 ), which express a high level of a1-containing receptors (Hu et al., 2014) , whereas RS cells are largely pyramidal neurons, which express multiple a isoforms (Bosman et al., 2002) . The bimodal effect of light is consistent with the inhibitory microcircuit of the cortex, which includes an extensive network of interneuron-interneuron synaptic connections. Hence, spike rate in an interneuron will tend to decrease when its own GABA A receptors are more active, and increase when GABA A receptors on presynaptic interneurons are more active. Understanding when and where direct inhibition or disinhibition dominates in the circuit is an important question that LiGABAR will help to answer.
g oscillations are thought to be mediated primarily by reciprocal interactions between excitatory and inhibitory neurons (E-I) or by reciprocal interactions within networks of inhibitory neurons (I-I) (Bartos et al., 2007; Buzsá ki and Wang, 2012) . Consistent with a crucial role for GABA, nonselective blockade of all GABA A receptor isoforms dampens g oscillations (Hasenstaub et al., 2005) . Surprisingly, we observed the opposite effect when we photo-antagonized specifically a1-containing GABA A receptors: enhancement of g power (increase of 28% ± 10%, n = 3, p < 0.05, Friedman test over episodes; Figures 8E  and 8F ). Experiments on control mice infused with vehicle alone showed no significant change in g power (increase of 2% ± 1%, n = 4, p > 0.05, Friedman test over episodes; Figures 8E and 8F) . Inhibitory synapses between PV cells (I-I connections) are highly enriched with a1-containing receptors (Klausberger et al., 2002) . Hence, our results support a crucial role of I-I in g rhythmogenesis.
DISCUSSION
LiGABAR Brings Optogenetic Control to the Synapse LiGABAR, like other optogenetic tools, enables precise and accurate manipulation of signals in the nervous system. But instead of manipulating an exogenous conductance added to a neuron, the signal being manipulated by LiGABAR is generated from within, by an endogenous neurotransmitter receptor. This enables interrogation of endogenous receptor function across broad levels of neural organization, from the molecular and cell biology of GABA A receptors in individual neurons to the systems biology of GABA A receptors in brain regions.
In principle, an endogenous protein could be made light sensitive by chemical modification with a synthetic photoswitch or by protein engineering with a light-sensitive module (e.g., the LOV domain; Gautier et al., 2014) . In practice, only the chemical approach has been applied successfully to neurotransmitter receptors (Gautier et al., 2014; Kramer et al., 2013) . Chemical photosensitization requires only a single amino acid substitution, allowing a receptor to retain its normal expression, trafficking, and activity. In contrast, light-sensitive domains are large (e.g., >100 amino acids for LOV), and splicing a bulky domain into a receptor is likely to alter or disrupt its function. Chemical modification, in this regard, may be the only feasible way to confer light sensitivity onto an endogenous neurotransmitter receptor.
Our results show that conjugating a PTL onto a modified GABA A receptor occurs quickly and efficiently in the brain under physiological conditions. The PTL can be applied either on the exposed surface of the brain or infused into neural tissue. In principle, both the compound and the light can be delivered to any part of the brain with an optrode containing both a capillary and an optic fiber (Berglind et al., 2014) .
At the cellular level, LiGABARs can be used to dissect the functions of different GABA A isoforms within a neuron. Independent photo-control offers a way to compare the geographical distribution, synaptic versus extrasynaptic localization, and functional impact of different isoforms. For example, our uncaging results (Figure 2 ) suggest that the a1 isoform is concentrated at synapses whereas a5 is broadly distributed, consistent with prior observations by immunolabeling (Brü nig et al., 2002; Kasugai et al., 2010) .
At ceptors mediate both presynaptic and postsynaptic inhibition (Kullmann et al., 2005; Farrant and Nusser, 2005) , but unraveling these processes can be difficult. Presynaptic inhibition can be detected by measuring a decrease in neurotransmitter release, but there is no surefire way to selectively manipulate presynaptic GABA A receptors without also affecting postsynaptic GABA A receptors. By genetically targeting LiGABAR to the presynaptic cell, photo-control can be exerted selectively, elucidating the impact of different forms of inhibition on circuit function and behavior.
At the organism level, the a1-GABA A PhoRM mouse offers the unique opportunity to reversibly and specifically photo-antagonize an endogenous neurotransmitter receptor in vivo, revealing its role in neural information processing and behavior. In principle, the same optical manipulation can be carried out with knockin mice for all of the other isoforms, elucidating their individual functions both in the normal brain and in neurological diseases. Because of their absolute subtype specificity in receptor photo-control, GABA A PhoRM mice may also be useful for target validation in drug discovery.
Practical Considerations Specificity
Control of LiGABAR is sufficiently specific, fast, and powerful to enable broad applications in neuroscience. Although some membrane proteins have free extracellular cysteines that could possibly be decorated by the PTL, we have detected no off-target electrophysiological effects on wild-type GABA receptors, glutamate receptors, or voltage-gated ion channels ( Figure S3 ). Additional control experiments may be warranted for new applications of LiGABAR to rule out unintended consequences.
Light Requirements
We have shown that a1-LiGABAR can be photo-controlled within 100 ms with an LED light source of $5-mW/mm 2 intensity (Figure 4) . Brighter light could result in even faster photoswitching, as suggested by studies on light-gated glutamate receptors (Reiner and Isacoff, 2014) . The optimal wavelengths for azobenzene photoswitching are 360-400 nm for trans-to-cis and 460-560 nm for cis-to-trans isomerization, but the action spectra may be tuned via structural modifications on the azobenzene core (Izquierdo-Serra et al., 2014) . Once switched to the cis state, the thermal stability of the PTL ensures that LiGABAR remains lodged in that state for >10 min in darkness (Figure 4 ). Brief intermittent flashes of 380-nm light (e.g., 200 ms at 1/min) can keep the PTL in the cis state indefinitely. For a trans-antagonist this is an important feature, because it ensures relief of antagonism in darkness until the onset of 500-nm light. For a2-a6, we have developed cis-antagonists such that the receptors operate normally in darkness and are antagonized only when exposed to 380-nm light.
Limitations to Photo-Control Photo-antagonism of LiGABAR is strong, but it can never be absolutely complete even with saturating light. Several factors may contribute to incomplete photoswitching. Conjugation of the PTL might be incomplete, leaving some receptors insensitive to light. Alternatively, antagonism may be limited by the affinity of the PTL for the GABA-binding site. Thus, a high concentration of GABA during synaptic transmission (Auger et al., 1998 ) might transiently outcompete the PTL. Moreover, most neurons express multiple a isoforms of GABA A receptors, and only receptors incorporating the mutant isoform will be subject to photoswitching.
Gene Delivery
The gene of a mutant a subunit can be overexpressed in a neuron, for example with a viral vector, or substituted for the wild-type gene, for example in a knockin mouse. Viral expression can be directed to a specified cell type with a customized vector, whereas gene substitution will occur in all cell types in the knockin mouse. If the experimental goal is to understand the physiological or behavioral function of a given a isoform, then the knockin mouse is preferable for preserving the normal expression profile. If the goal is to understand the function of an inhibitory connection in a neural circuit, then viral overexpression may be preferable for restricting photo-control to a particular locus in the circuit. Users will need to weigh the benefit of achieving cell-specific expression against the uncertainty of overexpression, which might alter the natural level or distribution of GABA A receptors. The CRISPR (clustered regularly interspaced short palindromic repeat)/Cas9 system allows gene substitution in terminally differentiated cells in vivo (Platt et al., 2014) , and we look forward to the time when exact genomic substitution of any a subunit can be achieved in an adult animal in a cell-type-specific manner.
EXPERIMENTAL PROCEDURES
The photoswitch compounds were synthesized as trifluoroacetate salts. The compounds were prepared as concentrated stocks (10-100 mM in anhydrous DMSO) and diluted in buffers for receptor conjugation (final DMSO concentration <1% v/v). AAV9 (10 12 to 10 13 vg/ml; viral genomes/ml) encoding a mutant a subunit (a1T125C or a5E125C), an eGFP marker, and a human synapsin-1 promoter was prepared by the UC Berkeley Gene Delivery Module following previously published procedures (Lin et al., 2014) . The a1-GABA A PhoRM mice were generated by the UC Davis Mouse Biology program. All experiments were performed in accordance with the guidelines and regulations of the Animal Care and Use Committee at the University of California, Berkeley. Group data are reported as mean ± SEM. Detailed experimental procedures and data analysis methods are available in Supplemental Experimental Procedures.
Mutant Expression and PTL Treatment
Ex Vivo Procedures: HEK Cells, Cultured Neurons, and Brain Slices HEK cells and dissociated hippocampal neurons were cultured on poly-Llysine-coated coverslips, maintained at 37 C and 5% CO 2 , and transfected via calcium phosphate precipitation. The mutant subunits were expressed in organotypic hippocampal slices by injecting AAV9 encoding eGFP-2A-a1T125C or eGFP-2A-a5E125C in the CA1 pyramidal cell body layer. Viral transduction of mouse cerebral cortex was performed by neonatal injection (Figures 3 and 4) or stereotactic injection in adult mice (Figures 5 and 6 ). Prior to electrophysiological experiments, the cells or slices were treated with Tris(2-carboxyethyl)phosphine (TCEP; 2.5-5 mM, 5-10 min), washed, and then treated with PTL (25-50 mM, 25-45 min) at room temperature to convert the mutant receptors into LiGABARs. In Vivo PTL Treatment For the experiments in Figures 5 and 6 , we made a craniotomy of 2-3 mm in diameter with subsequent duratomy on anesthetized mice. We applied 100 ml of HEPES-aCSF, which contained PAG-1C (250 mM) and TCEP (250-500 mM), onto the exposed cortex for 1 hr. For multielectrode recordings in awake mice (Figure 8) , we thinned the skull and opened a small craniotomy (0.5-1.5 mm in diameter) without duratomy over the visual cortex. The PTL solution was infused into the brain at a rate of 100 nl/min for 10 min with a glass micropipette attached to a microinfusion pump (UMP3 with SYS-Micro4 controller; World Precision Instruments). In control experiments, vehicle solution containing 500 mM TCEP without PAG-1C was infused.
Subcellular LiGABAR Mapping via Two-Photon GABA Uncaging Imaging and uncaging were performed using a two-photon laser-scanning microscope (MOM; Sutter). The light source for fluorescence excitation (800 nm for Alexa Fluor 594 and 940 nm for gephyrin intrabody) and RuBi-GABA uncaging (800 nm) was a Ti:sapphire laser (Chameleon XR; Coherent). LiGABAR-expressing hippocampal neurons were voltage clamped at 0 mV, with 25 mM DNQX (6,7-dinitroquinoxaline-2,3-dione), 50 mM D-AP5 [D-(À)-2-amino-5-phosphonopentanoic acid], and 0.5 mM TTX (tetrodotoxin) in the bath. The internal solution included 200 mM Alexa Fluor 594 (Life Technologies) for visualizing dendritic morphology. RuBi-GABA (200-400 mM; Abcam) was added to aCSF and recirculated using a peristaltic pump (Idex). Uncaging was carried out at designated locations for 5-10 ms with a light intensity of $150 mW. Full-field 390-nm (1.2 mW/mm 2 ) or 540-nm (3.2 mW/mm 2 ) conditioning flashes (5 s) from an LED light source (Lumencor) were delivered through the objective. Photoswitching was calculated as 1 À (I 540 /I 390 ), where I refers to the peak amplitude of GABA-elicited current.
Photo-Control of LiGABAR In Vivo
Visual stimulus generated with Psychtoolbox (http://psychtoolbox.org) was either a circular patch of drifting square-wave gratings in full contrast ( Figure 6 ) or a square full-contrast checkerboard (Figure 8 ) against a mean luminance gray background. Targeted loose-patch recordings for Figure 6 were made from PV-tdTOM and LiGABAR-eGFP double positive cells in layer 2/3 (150-350 mm below pia) of the visual cortex, using a two-photon laser-scanning microscope (Sutter) with a Ti:sapphire laser (1,050 nm; Coherent). Data were filtered at 2 kHz and digitized at 20 kHz using a BNC-2090 analog-to-digital convertor (National Instruments). For multielectrode extracellular recordings (Figure 8 ), a 16-channel probe (A1x16-3mm-25-177-A16; NeuroNexus) was used. Recordings were amplified and digitized at 30 kHz (SpikeGadgets). MClust (http://redishlab.neuroscience.umn.edu/MClust/MClust.html) was used for offline sorting of the spike waveforms. 
SUPPLEMENTAL INFORMATION

